Skip to main content
. Author manuscript; available in PMC: 2015 Apr 30.
Published in final edited form as: Respirology. 2014 Oct 19;20(1):108–114. doi: 10.1111/resp.12421

Table 3.

Prevalence of exacerbations and comorbidities and radiological measurements

Characteristics Menthol Non-menthol P-value
Exacerbations
 Exacerbations per annum 0.47 ± 1.97 0.49 ± 1.66 0.245
 Severe exacerbations per annum 0.22 ± 0.99 0.18 ± 0.98 0.008
Comorbidity
 Cardiovascular disease 6.5 10.4 <0.001
 Congestive heart failure 2.2 2.9 0.106
 Peripheral vascular disease 1.5 2.5 0.007
 Cerebrovascular disease 3.7 3.8 0.866
 Hypertension 38.9 36.9 0.148
 Diabetes 12.4 11.5 0.304
 Gastro-oesophageal reflux 17.6 22.8 <0.001
 Osteoporosis 4.6 8.6 <0.001
CT measurements
 Emphysema percentage 3.1 ± 5.9 4.2 ± 7.2 <0.001
 Gas trapping percentage 15.5 ± 15.6 19.0 ± 17.7 <0.001
 Segmental wall area (%) 61.7 ± 3.3 61.7 ± 3.4 0.551
 Pi10 3.7 ± 0.1 3.7 ± 0.1 0.252

Data are presented as mean ± standard deviation or %.

CT, computed tomography; Pi10, square root of the luminal perimeter of a standardized airway of 10-mm diameter.